Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Introduction: Brain arteriovenous malformations (AVM) are complex vascular pathologies with a significant risk of hemorrhage. Stereotactic radiosurgery (SRS) is an effective treatment modality for AVM, initially popularized on the Gamma Knife (Elekta AB, Stockholm, Sweden) platform, and now benefits from the modern advances in linear accelerator (LINAC)-based platforms. This study evaluates the outcomes of LINAC-based SRS/hypofractionated stereotactic radiotherapy (hFSRT) for cerebral AVMs.
Materials And Methods: Between December 2018 and April 2024, 15 patients with cerebral AVMs underwent SRS/hFSRT at a tertiary government hospital. Patient selection was based on AVM size, location, surgical unsuitability, and patient preference. All patients underwent MRI and cerebral angiography for nidus delineation. SRS was planned using Monaco TPS (treatment planning system) (Elekta AB, Stockholm, Sweden) with VMAT (volumetric modulated arc therapy) technique, delivering a median dose of 20 Gy in single fractions for small AVMs and 28 Gy in four fractions for large AVMs. Patients were followed up with annual MRI and angiography to assess obliteration.
Results: The cohort had a median age of 22 years, with a median nidus volume of 3.76 cc. The crude obliteration rate was 60%, confirmed by MRI/angiography. Actuarial obliteration rates at two, three, and five years were 65.71%, 73.57%, and 77.14%, respectively. Smaller AVMs (<3 cc) and those with a modified AVM radiosurgery score <1.5 had nearly 100% obliteration rates. Large AVMs (>10 cc) treated with hypofractionated SRT showed partial responses only. Significant predictors of obliteration included prescription dose, AVM volume, and modified AVM radiosurgery score.
Conclusion: LINAC-based SRS demonstrates comparable efficacy to other modalities for treating cerebral AVMs, with obliteration rates influenced by dose, AVM volume, and pre-treatment radiosurgery score. Larger AVMs pose a greater challenge, suggesting a need for adjunctive treatments or higher fractionated doses to improve outcomes.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11751660 | PMC |
| http://dx.doi.org/10.7759/cureus.76232 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Mesoporous Zr MOFs regulated by linear ligand replacement strategy to achieve single Ru(bpy) molecule encapsulation for ratio ECL detection of miRNA-21.
Talanta
September 2025
College of Chemistry and Chemical Engineering, College of Materials Science and Engineering, Shandong Sino-Japanese Center for Collaborative Research of Carbon Nanomaterials, Qingdao Application Technology Innovation Center of Photoelectric Biosensing for Clinical Diagnosis and Treatment, Instrument
Rational optimization of the pore size and topology of porous nanocarriers is crucial for improving the loading amount of luminophore and enhancing electrochemiluminescence (ECL) performance. In this study, an equimolar linear ligand replacement strategy was employed to synthesize novel mesoporous metal-organic frameworks (MOFs) for encapsulating Ru(bpy) (Ru@Zr MOFs) under room temperature without an acid modulator. Ingenious ligand substitution allows precise control of pore size, enabling encapsulation at the single-molecule level within mesoporous cages.
View Article and Find Full Text PDFEnhancing dosimetric precision in the treatment of cancerous tumors: Gamma Index validation and Monte Carlo simulations of 6 and 12 megavoltage photon beams from Varian Medical linear accelerators.
Front Oncol
August 2025
Department of Radiological Sciences, College of Applied Medical Sciences, Najran University, Najran, Saudi Arabia.
Introduction: The accuracy of dose delivery in radiotherapy is paramount to maximize tumor control while minimizing damage to surrounding healthy tissues. This study presents a comprehensive analysis of gamma index validation in the treatment of cancerous tumors using Monte Carlo simulations with GAMOS and GATE codes on a Varian medical linear accelerator. By leveraging the MC method's robust statistical capabilities, the precision of dose distributions in external radiotherapy is aimed to be enhanced.
View Article and Find Full Text PDFDosimetric accuracy of low dose rate volumetric modulated arc therapy delivery in an Elekta Versa HD linear accelerator for pulsed low dose rate treatment of recurrent high-grade glioma using Monaco planning system: Low dose rate VMAT-based PLDR in Elekta Linac.
J Appl Clin Med Phys
September 2025
Department of Physics, School of Advanced Sciences, Vellore Institute of Technology, Vellore, Tamilnadu, India.
Background And Purpose: Reducing the dose rate enhances efficacy in radiation therapy by allowing increased repair of sub-lethal damage. Pulsed low-dose radiation therapy (PLDR) is an innovative approach that is safe and effective for the reirradiation of recurrent gliomas and radioresistant tumors. In this study, the accuracy of the low dose rate volumetric modulated arc therapy (VMAT) delivery is tested in an Elekta Versa HD linear accelerator (linac) for delivering PLDR.
View Article and Find Full Text PDFEfficient MLC quality assurance using a virtual picket fence test in an MR-Linac.
J Appl Clin Med Phys
September 2025
Medical Physics Division, Department of Medical Innovation & Technology, CUHK Medical Centre, Hong Kong SAR, China.
Background: The Elekta Unity MR-Linac system integrates magnetic resonance imaging (MRI) with a linear accelerator (Linac) for adaptive radiation therapy. Traditional quality assurance (QA) methods for multi-leaf collimators (MLCs) face challenges in this system due to the magnetic field and limited field size of electronic portal imaging devices (EPID).
Purpose: This study aims to develop a 'virtual picket fence' test using machine log files to evaluate MLC performance in the Elekta Unity MR-Linac system, providing a more efficient and comprehensive QA method that overcomes the limitations of traditional approaches.
Enhancing patient-specific quality assurance in MR-guided radiation therapy: A fluence-based method using log files.
J Appl Clin Med Phys
September 2025
Medical Physics Division, Department of Medical Innovation & Technology, CUHK Medical Centre, Hong Kong SAR, China.
Background: Patient-specific quality assurance (PSQA) is crucial in radiation therapy to ensure accurate and safe dose delivery. The Elekta Unity MR-Linac system, which combines MRI with a linear accelerator, presents unique challenges for conventional PSQA methods due to its adaptive capabilities and the presence of a magnetic field.
Purpose: This study introduced a novel PSQA method for the Elekta Unity MR-Linac system, utilizing treatment log files and fluence map verification to provide a more efficient alternative to traditional measurement-based techniques.